ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 125 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $120,541,385 | -29.2% | 26,204,649 | -0.6% | 0.11% | -24.1% |
Q2 2023 | $170,316,292 | +13.9% | 26,364,751 | +33.0% | 0.14% | +7.4% |
Q1 2023 | $149,515,570 | -25.1% | 19,829,651 | +0.7% | 0.14% | -35.1% |
Q4 2022 | $199,527,925 | +51.0% | 19,696,735 | +47.5% | 0.21% | +52.9% |
Q3 2022 | $132,109,000 | -7.1% | 13,357,668 | +0.0% | 0.14% | -6.8% |
Q2 2022 | $142,227,000 | +32.0% | 13,354,715 | +20.9% | 0.15% | +92.1% |
Q1 2022 | $107,725,000 | +110.8% | 11,048,765 | +209.2% | 0.08% | +171.4% |
Q4 2021 | $51,108,000 | -21.3% | 3,573,908 | +10.3% | 0.03% | -17.6% |
Q3 2021 | $64,940,000 | +8.3% | 3,240,543 | +18.9% | 0.03% | +17.2% |
Q2 2021 | $59,954,000 | +52.8% | 2,725,197 | +135.9% | 0.03% | +31.8% |
Q1 2021 | $39,235,000 | – | 1,155,353 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |